When treated with TNF-α and 17-DMAG together, the viabilities of the three lung cancer cell lines MS-1 (Figure 1B), A549 (Figure 1C), and LK-2 (Figure 1D) were reduced by more than 80% at day 2 and by 90% at day 3. The gene discussed is TNF; the disease is lung carcinoma.